Brokerages Set Revvity Inc. (NYSE:RVTY) PT at $113.67

Revvity Inc. (NYSE:RVTY) has been given an average rating of “Hold” by the fourteen research firms that are covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, eight have given a hold recommendation and five have assigned a buy recommendation to the company. The average twelve-month price target among brokers that have issued ratings on the stock in the last year is $113.6667.

A number of research firms have recently weighed in on RVTY. Jefferies Financial Group lifted their target price on Revvity from $100.00 to $105.00 and gave the stock a “hold” rating in a report on Monday, February 2nd. TD Cowen reiterated a “hold” rating on shares of Revvity in a research note on Tuesday, February 3rd. The Goldman Sachs Group began coverage on shares of Revvity in a report on Tuesday, December 9th. They issued a “neutral” rating and a $105.00 price objective for the company. JPMorgan Chase & Co. increased their target price on shares of Revvity from $100.00 to $105.00 and gave the stock a “neutral” rating in a research report on Tuesday, February 3rd. Finally, Weiss Ratings reiterated a “sell (d)” rating on shares of Revvity in a research report on Monday, December 29th.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of the stock. CYBER HORNET ETFs LLC bought a new stake in Revvity during the second quarter worth about $32,000. Cromwell Holdings LLC raised its position in shares of Revvity by 141.4% in the 4th quarter. Cromwell Holdings LLC now owns 338 shares of the company’s stock valued at $33,000 after buying an additional 198 shares in the last quarter. MUFG Securities EMEA plc bought a new stake in shares of Revvity during the 2nd quarter worth approximately $34,000. CVA Family Office LLC boosted its position in shares of Revvity by 79.0% during the 2nd quarter. CVA Family Office LLC now owns 410 shares of the company’s stock worth $40,000 after acquiring an additional 181 shares in the last quarter. Finally, Headlands Technologies LLC bought a new position in Revvity in the second quarter valued at approximately $49,000. Institutional investors own 86.65% of the company’s stock.

Revvity Trading Down 3.3%

Shares of RVTY stock opened at $97.01 on Thursday. Revvity has a 12-month low of $81.36 and a 12-month high of $120.39. The company has a market capitalization of $11.00 billion, a PE ratio of 46.64, a price-to-earnings-growth ratio of 2.13 and a beta of 1.06. The firm has a 50 day moving average price of $103.17 and a two-hundred day moving average price of $96.22. The company has a quick ratio of 1.40, a current ratio of 1.68 and a debt-to-equity ratio of 0.36.

Revvity (NYSE:RVTY) last announced its earnings results on Monday, February 2nd. The company reported $1.70 earnings per share for the quarter, topping analysts’ consensus estimates of $1.55 by $0.15. The company had revenue of $772.06 million for the quarter, compared to analyst estimates of $759.81 million. Revvity had a return on equity of 7.92% and a net margin of 8.45%.The firm’s quarterly revenue was up 5.9% compared to the same quarter last year. During the same quarter last year, the company earned $1.42 earnings per share. Revvity has set its FY 2026 guidance at 5.350-5.450 EPS. As a group, analysts predict that Revvity will post 4.94 earnings per share for the current year.

Revvity Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 8th. Shareholders of record on Friday, April 17th will be issued a $0.07 dividend. The ex-dividend date of this dividend is Friday, April 17th. This represents a $0.28 annualized dividend and a yield of 0.3%. Revvity’s payout ratio is currently 13.46%.

Revvity announced that its board has authorized a share repurchase plan on Monday, October 27th that authorizes the company to buyback $1.00 billion in shares. This buyback authorization authorizes the company to repurchase up to 8.7% of its stock through open market purchases. Stock buyback plans are often an indication that the company’s board believes its stock is undervalued.

Revvity Company Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.